Dr. Robert Aiken

Dr. Robert Aiken is a fellowship-trained neuro-oncologist and part of the Atlantic Medical Group Neuroscience Institute at Overlook Medical Center. With years of expertise in academic, clinical and administrative roles, and board-certified in neurology and neuro-oncology, he specializes in the diagnosis and management of patients with brain tumors, tumors of the spinal cord and nerves, as well as the management of paraneoplastic disorders involving the brain and nervous system. His particular interest involves translating new discoveries and developing new therapies for these disorders. A devoted researcher and educator, Dr. Aiken serves as co-director of the Gerald J. Glasser Brain Tumor Center at Atlantic Health System. He also served as director of neuro-oncology at Rutgers-Cancer Institute of New Jersey of Rutgers University. Previously, he held academic appointments in neurology, neurosurgery and oncology at Mount Sinai School of Medicine in NYC and Rush University Medical Center in Chicago. He combines clinical knowledge and extensive research in brain and spinal tumors. Dr. Aiken provides patients with a comprehensive evaluation and discusses their disease at length and the available treatments. After receiving his medical degree from Wayne State University School of Medicine in Detroit, MI, Dr. Aiken completed an internship and residency in internal medicine at Baylor College of Medicine in Houston, TX, then pursued neurologic training at the Neurological Institute of New York, Columbia-Presbyterian Medical Center. Post-residency, Dr. Aiken received his fellowship training at Memorial Sloan-Kettering Cancer Center. He is the author of many professional research journal articles. Dr. Aiken has been named among America’s Top Doctors and America’s Top Doctors for Cancer from Castle Connolly, Best Doctors in Philadelphia, New York and Chicago and by Inside Jersey magazine. He is on many best doctors lists. Dr. Aiken is part of Atlantic Medical Group and a participating provider of the Atlantic Accountable Care Organization.

Dr. Aiken is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliosarcoma.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 18 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles and participated in 14 clinical trials in the study of Glioblastoma.